GlobalData on MSN3d
Nevro secures CE mark for AI-based spinal cord stimulation systemUS-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...
A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...
A team of researchers led by Rice University's Jacob Robinson and the University of Texas Medical Branch's Peter Kan has ...
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...
Philadelphia-based Rothman Orthopaedic Institute has been at the forefront of spine care, and recently a team partnered with Thomas Jefferson University Hospita ...
WATE Knoxville on MSN3d
‘I’m in pain every day’ Retired Knoxville firefighter seeks workers’ comp solution after career-ending injuryKNOXVILLE, Tenn. (WATE) — Chris Patterson was a Knoxville fire captain when he rescued a woman from a house fire in December ...
The company announced receiving CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. Nevro raised ...
Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.
Utilizing the Dural Substitute Confetti technique during spinal cord stimulation trial implantation may reduce complications and shorten surgery time.
which has been awarded ten Breakthrough Device Designations from the US Food and Drug Administration (FDA). ONWARD ARC ...
The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...
NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback